$CMPX

4 theses

bullish 50%neutral 50%bearish 0%

Avg return (1y)

—

Win rate (1y)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices delayed ~15 min · refreshed 3m ago

$CMPXr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄neutral

u/Avish_Golakiya · 23h ago31 prior · 63% at 3mo

“I'm [holding / not adding] until I see what the FDA feedback means for a filing.”

10 penny biotechs I'm watching and slowly adding for October/November 2026, and the one I got wrong in September.

CMPX is trading below cash with $180M cash against $147M market cap and 34 months of runway, providing downside protection. An ESMO oral presentation on Oct 24 and FDA feedback on a biliary-tract-cancer therapy create a near-term catalyst, though the recent SEC feedback has caused uncertainty.

At post $0.81Now $0.79-3.6% since posted3m ago

original post →

$CMPXr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄neutral

u/Avish_Golakiya · 45d ago31 prior · 63% at 3mo

“Watching, presented at ESMO”

10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.

COMPANION-002 Phase 2 met primary response rate endpoint (17.1% vs 5.3%, PFS HR 0.44) but missed overall survival (8.9 vs 9.4 months, HR 1.05, p=0.78). Author flags control-arm crossover as confound; ESMO presentation Oct 23 will enable peer scrutiny of the shortfall.

At post $2.21Now $0.79-64.5% since posted3m ago

1d—

3d-7.2%

1w-11.3%

1m-53.8%

3m—

6m—

1y—

original post →

$CMPXr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish

u/Avish_Golakiya · 78d ago31 prior · 63% at 3mo

10 penny biotechs I'm watching for August 2026, and adding slowly

Compass Therapeutics' tovecimig (DLL4 x VEGF-A bispecific) has Oct 2024 data in biliary tract cancer. The company carries 31 months of runway, 41% short float, and insider officer purchases; structural setup mirrors other small-float, well-funded biotech volatility plays with dated catalysts.

At post $1.89Now $0.79-58.5% since posted3m ago

1d+5.3%

3d+13.8%

1w+25.4%

1m+25.9%

3m—

6m—

1y—

original post →

$CMPXr/pennystocksGeneral Discussionbullish

u/IndividualLetter4329 · 152d agono track record yet

CMPX is A stock to watch!

Analysts project CMPX to reach $4 within a year, with some forecasts as high as $10–$30. The author expects the stock to rally on Monday with proper volume.

At post $2.20Now $0.79-64.3% since posted3m ago

1d—

3d+3.2%

1w+8.2%

1m-6.4%

3m+9.1%

6m—

1y—

original post →

End of results.